GENE ONLINE|News &
Opinion
Blog

HeFH
IPO Heart Disease
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Funding Cholesterol
Verve Raises $94M in Series B, Aims to Disrupt Cardiology Market with ‘Once-and-Done’ Gene Editing Therapies
2021-01-21
R&D Immunotherapy
Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy
2020-11-22
R&D LDL
Regeneron’s Antibody Therapy Reduces LDL Cholesterol in Hypercholesterolemia Patients
2020-11-21
Cancer
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
Trials & Approvals Cholesterol
FDA Approval of Cholesterol Lowering Drug, NEXLETOL, A Value-Add to Existing Treatments
2020-02-25
LATEST
Breakthrough Stem Cell Treatment Shows Promise in Reversing Liver Disease
2023-12-08
2023 Taiwan Healthcare Expo: Showcasing Innovative Advances in Biomedical Technology
2023-12-07
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top